Transition report pursuant to Rule 13a-10 or 15d-10

Unaudited Interim Condensed Consolidated Statements of Stockholders' Equity

v3.22.0.1
Unaudited Interim Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning Balance (in shares) at Sep. 30, 2020   25,268,848      
Beginning Balance at Sep. 30, 2020 $ 11,080 $ 3 $ 48,215 $ 0 $ (37,138)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   10,617      
Issuance of common stock upon exercise of stock options 2   2    
Issuance of common stock upon settlement of restricted stock units (in shares)   790,497      
Stock-based compensation - restricted stock 1,027   1,027    
Stock-based compensation - stock options 248   248    
Comprehensive income:          
Net income (loss) (2,361)       (2,361)
Ending Balance (in shares) at Dec. 31, 2020   26,069,962      
Ending Balance at Dec. 31, 2020 9,996 $ 3 49,492 0 (39,499)
Beginning Balance (in shares) at Sep. 30, 2021   70,096,401      
Beginning Balance at Sep. 30, 2021 291,229 $ 7 368,709 (297) (77,190)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   893,509      
Issuance of common stock upon exercise of stock options 161   161    
Issuance of common stock upon settlement of restricted stock units (in shares)   51,848      
Stock-based compensation - restricted stock 2,931   2,931    
Shares withheld related to net share settlement (in shares)   (374,377)      
Shares withheld related to net share settlement (3,121)   (3,121)    
Comprehensive income:          
Net income (loss) 772       772
Other comprehensive loss (601)     (601)  
Ending Balance (in shares) at Dec. 31, 2021   70,667,381      
Ending Balance at Dec. 31, 2021 $ 291,371 $ 7 $ 368,680 $ (898) $ (76,418)